| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/09/2012 | CN101850227B Preparation method for nano particle and nano-particle sol and application of nano particle and nano-particle sol in magnetic resonance imaging contrast medium |
| 05/08/2012 | US8173839 5-aminolevulinic acid salt, process for producing the same and use thereof |
| 05/08/2012 | US8173443 Multiplex screening for lysosomal storage disorders (LSDs) |
| 05/08/2012 | US8173376 Method for identifying compounds for treatment of pain |
| 05/08/2012 | US8173176 Embolization |
| 05/08/2012 | US8173139 High energy electron beam irradiation for the production of immunomodulators in poultry |
| 05/08/2012 | US8173105 Contrast agents and methods for preparing contrast agents |
| 05/08/2012 | US8173104 Controlled-release immunogenic formulations to modulate immune response |
| 05/08/2012 | US8173103 Inhibition of cancer metastasis |
| 05/08/2012 | CA2377661C Use of fatty acid derivative for the treatment of external secretion disorders |
| 05/03/2012 | WO2012058418A2 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy |
| 05/03/2012 | WO2012056447A1 Isotopically labeled deoxy-glucose and derivatives thereof, compositions comprising them and uses thereof |
| 05/03/2012 | WO2012055020A1 Thermosensitive liposomes |
| 05/03/2012 | WO2012002760A3 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 05/03/2012 | WO2012002759A3 Microvesicles derived from cell protoplast, and use thereof |
| 05/03/2012 | WO2011133685A3 Nanoparticle targeting to ischemia for imaging and therapy |
| 05/03/2012 | US20120110682 Animal Model for Toxicology and Dose Prediction |
| 05/03/2012 | US20120109045 Encapsulation of Microbubbles Within the Aqueous Core of Microcapsules |
| 05/03/2012 | US20120107827 PSMCs As Modifiers of the RB Pathway and Methods of Use |
| 05/03/2012 | US20120107342 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 05/03/2012 | US20120107249 Diagnostic Imaging Contrast Agents with Extended Blood Retention |
| 05/03/2012 | US20120107248 Imaging gastrointestinal volumes and motility |
| 05/03/2012 | US20120107247 Proteins Expressed by Mycobacterium Tuberculosis and not by BCG and their Use as Diagnostic Reagents and Vaccines |
| 05/03/2012 | US20120107246 Methotrexate-modified nanoparticles and related methods |
| 05/03/2012 | US20120107245 Dental composition for detection of carious tissue, detection method |
| 05/03/2012 | US20120107244 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611 |
| 05/03/2012 | US20120107243 Peptide-mediated non-covalent delivery of active agents across the blood-brain barrier |
| 05/03/2012 | US20120107242 Nucleic acid-mediated shape control of nanoparticles for biomedical applications |
| 05/03/2012 | US20120107241 Particles for Inhalation Having Sustained Release Properties |
| 05/03/2012 | US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 05/03/2012 | US20120107229 Novel nano-probes for molecular imaging and targeted therapy of diseases |
| 05/03/2012 | CA2816358A1 Compositions targeting the soluble extracellular domain of e-cadherin and related methods for cancer therapy |
| 05/02/2012 | EP2447269A2 Gadolinium complex, method for preparing same, and mri contrast agent comprising same |
| 05/02/2012 | EP2445932A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery |
| 05/02/2012 | EP2445539A1 Therapeutic antibody target validation and screening in vivo |
| 05/02/2012 | EP2054165B9 Method of covering self-assembled metal or inorganic surfaces with gem-bisphosphonic compounds and uses thereof |
| 05/02/2012 | EP1768704B1 Imaging infection with compounds that bind to thymidine kinase |
| 05/02/2012 | EP1421389B1 Neurofibrillary labels |
| 05/02/2012 | CN102438659A Optical imaging agents |
| 05/02/2012 | CN102436886A Method for preparing gold-coated magnetic composite nanoparticles |
| 05/02/2012 | CN102436885A Method for dispersing iron-based magnetic nanocrystals |
| 05/02/2012 | CN102430132A Sterilization type medical ultrasonic coupling agent |
| 05/02/2012 | CN102430131A Antibacterial medical ultrasound compounding agent and preparation method thereof |
| 05/02/2012 | CN102430130A Medical modified glucan coated magnetic nanometer particle composite material and preparation method thereof |
| 05/02/2012 | CN102429868A Liposome medicinal composition with tumor targeting, in-vivo tracing and treating functions and preparation method thereof |
| 05/02/2012 | CN101676300B Antibody for inhibitting growth of colorectal carcinoma and its use in preparation of diagnostic agent of Colorectal cancer, endometrial carcinoma and pancreatic cancer |
| 05/02/2012 | CN101496904B Trichosanthin protein induced mouse allelgic asthma disease model |
| 05/01/2012 | US8168749 Stimulating neurite outgrowth using Tctex-1-related polypeptides |
| 05/01/2012 | US8168587 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 05/01/2012 | US8168402 Diagnostic tests of substance use disorders |
| 05/01/2012 | US8168223 Engineered particles and methods of use |
| 05/01/2012 | US8168165 Alkylated interleukin-18 compositions |
| 05/01/2012 | US8168160 Anti-inflammatory fusion protein |
| 05/01/2012 | CA2516455C Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 05/01/2012 | CA2475092C Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 05/01/2012 | CA2440794C Neurofibrillary labels |
| 04/26/2012 | WO2012054717A2 Detecting and treating solid tumors through selective disruption of tumor vasculature |
| 04/26/2012 | WO2012053306A1 Endoscopic observation method and composition for improving diagnostic performance involving applying useful white opaque substance to diagnosis of gastric epithelial tumors (adenoma/gastric cancer) |
| 04/26/2012 | WO2012020301A3 Oral controlled release pharmaceutical compositions of blonanserin |
| 04/26/2012 | WO2012018240A3 Preparation of extremely small and uniform sized, iron oxide-based paramagnetic or pseudo-paramagnetic nanoparticles and mri t1 contrast agents using the same |
| 04/26/2012 | WO2011123820A3 Single isomeric conjugates of rhodamine dyes |
| 04/26/2012 | WO2011053252A1 Polymer coated magnetic particles |
| 04/26/2012 | US20120102581 Multiplexed Luciferase Reporter Assay Systems |
| 04/26/2012 | US20120101390 Multi-Modal Imaging for Diagnosis of Early Stage Epithelial Cancers |
| 04/26/2012 | US20120100079 Stimuli-responsive carriers for mpi-guided drug delivery |
| 04/26/2012 | US20120100078 Pyrazine Derivatives and Uses Thereof in Renal Monitoring |
| 04/26/2012 | US20120100077 Mixture of amphipathic molecules and method for modifying cell membranes by means of fusion |
| 04/26/2012 | US20120100076 Methods of modulating cold sensory perception |
| 04/26/2012 | US20120100075 Fluorescent Gold Nanocluster Matrix |
| 04/26/2012 | US20120100074 Humanized antibodies against light and uses thereof |
| 04/26/2012 | US20120100070 Cyclic Peptide Analogues For Non-Invasive Imaging of Pancreatic Beta-Cells |
| 04/26/2012 | US20120100069 B-Lymphocyte Targeting Agents for Use in a Method for the Treatment of a Disease |
| 04/26/2012 | US20120100067 Solubilisation Method |
| 04/26/2012 | DE102010042833A1 Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung New Halogenalkoxychinazoline, their preparation and use |
| 04/25/2012 | EP2444099A1 Antibodies and related molecules that bind to 161P2F10B proteins |
| 04/25/2012 | EP1450859B1 Methods and compositions for the diagnosis of asthma |
| 04/25/2012 | CN102427829A Hiv-1的脂肽抑制剂 Hiv-1 lipopeptide inhibitor |
| 04/25/2012 | CN102427759A Site localization and methods for monitoring treatment of disturbed blood vessels |
| 04/25/2012 | CN102423494A CdTe/ZnS/聚醚/叶酸核壳型纳米颗粒的制法 CdTe / ZnS / polyether / folic acid core-shell nanoparticles prepared by |
| 04/25/2012 | CN101745126B 一种包载水溶性药物超声造影剂的制备方法 A method for preparing a water-soluble drug entrapped ultrasound contrast agents |
| 04/25/2012 | CN101337907B 一种纯化碘佛醇的方法 A method for the purification of ioversol |
| 04/24/2012 | US8163528 Nucleic acid molecules encoding thymidine kinase fusion proteins |
| 04/24/2012 | US8163294 Growth regulatable recombinant BCG compositions |
| 04/24/2012 | CA2268812C Method for producing transgenic animal models with modulated phenotype and animals produced therefrom |
| 04/19/2012 | WO2012051323A2 Cryptophane derivatives and methods of use thereof |
| 04/19/2012 | WO2012050896A2 Protease selective supramolecular assemblies |
| 04/19/2012 | WO2012050810A2 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging |
| 04/19/2012 | WO2012049657A1 Silica nanoparticles doped with multiple dyes featuring highly efficient energy transfer and tunable stokes-shift |
| 04/19/2012 | WO2012032524A9 Near infrared fluorescent particles and uses thereof |
| 04/19/2012 | WO2011153331A3 Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo |
| 04/19/2012 | US20120096568 Transgenic lsd1 animal model for cancer |
| 04/19/2012 | US20120095235 Thioflavin derivates for use in the antemortem diagnosis of alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 04/19/2012 | US20120093857 Vaccination and Immunotherapy as New Therapeutic Modalities in the Treatment of Glaucoma |
| 04/19/2012 | US20120093735 Complex compound and mri probe made of same |
| 04/19/2012 | US20120093734 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma |
| 04/19/2012 | US20120093733 Multidomain biotags for cancer detection, diagnosis and therapy and methods of their use |
| 04/19/2012 | US20120093732 Ultrasound contrast agents and methods of making and using them |
| 04/19/2012 | US20120093731 Gas-filled microvesicles with targeting ligand or therapeutic agent |
| 04/19/2012 | US20120093730 Molecular death tags and methods of their use |
| 04/19/2012 | US20120093729 Novel phosphorus-containing prodrugs |